Found 6 results
Author [ Title(Desc)] Type Year
Filters: Author is Brigham, GS  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., Korthuis, P., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., “Buprenorphine + Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study”, Addiction, vol. 111, no. 6, pp. 1416-1427, 2016.
C
W. Ling, Hillhouse, M., Thomas, C., Hasson, A., Annon, J., Mooney, L., Saxon, A., Blumberg, D., Weimer, W., Koosis, E., Brigham, G. S., Woody, G., Trivedi, M., Drexler, K., and Dawes, M., “Cocaine Use Reduction with Buprenorphine (CURB): Study Methods and Participant Characteristics”, in College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
D
T. M. Winhusen, Stitzer, M. L., Woody, G. E., Brigham, G. S., Kropp, F. B., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., “Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals”, Contemp Clin Trials, vol. 33, pp. 197-205, 2012.
M
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., Van Veldhuisen, P., Theobald, J., May, J., and Brigham, G. S., “Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
N
J. D. Lee, Nunes, E. V., Novo, P., Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale”, Contemp Clin Trials, 2016.
P
D. M. Donovan, Bigelow, G. E., Brigham, G. S., Carroll, K. M., Cohen, A. J., Gardin, J. G., Hamilton, J. A., Huestis, M. A., ,, Lindblad, R., Marlatt, G. A., Preston, K. L., Selzer, J. A., Somoza, E. C., Wakim, P. G., and Wells, E. A., “Primary Outcome Indices in Illicit Drug Dependence Treatment Research: Systematic Approach to Selection and Measurement of Drug Use End-Points in Clinical Trials”, Addiction, vol. 107, no. 4, pp. 694-708, 2012.